Shift4 Payments, UATP Partner to Support Travel Payment Solutions
UATP is a global payment solution collectively owned and operated by various airlines worldwide. It is widely accepted by thousands of merchants for payments related to air travel, rail services, and travel agencies. The network facilitates connections between airlines and Alternative Forms of Payment and broadens their reach and stimulates incremental sales globally.
A business person using a mobile point of sale device outside of a retail store.
UATP accounts are accepted for corporate business travel globally by airlines, travel agencies, and Amtrak. Accounts are currently issued by a range of airlines, which include Aeromexico, Air Canada, American Airlines, British Airways (via AirPlus International), Delta Air Lines, Etihad Airways, Japan Airlines, Qantas Airways, Turkish Airlines, and United Airlines.
Shift4 Payments Inc. (NYSE:FOUR) provides software and payment processing solutions in the US and internationally.
While we acknowledge the potential of FOUR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the .
READ NEXT: and .
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Cell and Gene Therapy Supply Chain Software Market Report 2025-2035: 170+ Software Solutions Providers Fueling Fragmented Cell & Gene Therapy Supply Chain Market Growth
The global cell and gene therapy supply chain software market is set to expand from USD 0.27 billion in 2025 to USD 1.32 billion by 2035, at a CAGR of 15.2%. Driven by demand for advanced therapies, the market is enhanced by cloud-based technologies and key players like Azenta Life Sciences and Lonza. Cell and Gene Therapy Supply Chain Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Supply Chain Software Market: Industry Trends and Global Forecasts to 2035: Distribution by Process Component, Type of Software, Mode of Deployment, Scale of Operation, Type of End-user and Key Geographical Regions" report has been added to offering. The global cell and gene therapy supply chain software market is estimated to grow from USD 0.27 billion in 2025, to USD 1.32 billion by 2035, at a CAGR of 15.2% during the forecast period, to 2035. CELL AND GENE THERAPY SUPPLY CHAIN SOFTWARE MARKET: GROWTH AND TRENDS Advanced therapies are gradually evolving the face of modern healthcare. These new regenerative and immunotherapy modalities have the potential to improve treatment outcomes by providing viable therapy solutions to patients who currently have limited or no treatment options. Given the nature of these treatment modalities, these therapies have a limited lifespan, even when shipped under temperature-controlled conditions. It becomes increasingly important to track the source of the sample from the time of its collection, current location and manufacturing processes. Following this fact, for the commercial success of such therapies, an effective manufacturing platform and a robust supply chain model are imperative. It is worth mentioning that a sustainable supply chain enables further reductions in the cost of goods and, in turn, prices of such therapies. The supply chain for innovative therapies is complicated from the outset and given the interdependencies amongst multiple stakeholders, it becomes challenging to manage and streamline the overall process. This has reinforced the need for bespoke and integrated software solutions to help innovators manage the critical intricacies of the supply chain. These software systems have huge potential to manage a multitude of events, maintain the chain of identity and custody, and enable stakeholders to optimize the complex supply chains, while also ensuring compliance with global regulatory standards. Driven by the growing demand for cell and gene therapies and the availability of easy to integrate software solutions to manage cell and gene therapy supply chain, this market is expected to grow significantly in the foreseen future. CELL AND GENE THERAPY SUPPLY CHAIN SOFTWARE MARKET: KEY INSIGHTS The report delves into the current state of the cell and gene therapy supply chain software market and identifies potential growth opportunities within the industry. Some key findings from the report include: Presently, close to 175 cell and gene therapy supply chain software solutions are available in the market; of these, 22% are laboratory information management systems. Over 20% of the cell and gene therapy supply chain software solutions can be deployed both on-premises and over the cloud, offering flexibility as well as contact-less options for the end-users. The current market landscape of cell and gene therapy supply chain software providers is fragmented, featuring the presence of both new entrants and established players; majority of these players are based in the US. The growing interest in this domain is evident from the rise in partnership activity; in fact, 40 partnership deals related to cell and gene therapy supply chain software were inked in 2023. Several investors, having realized the opportunities associated within supply chain management software domain, have invested USD 3 billion across various funding rounds in the past 10 years. Driven by the increasing pace of innovation and partnership activity, the market for cell and gene therapy supply chain software is poised to witness steady growth in the foreseeable future. The cell and gene therapy supply chain software market is anticipated to grow at a CAGR of 15.2%, till 2035; North America is expected to capture the majority share (over 45%) of the market by 2035. CELL AND GENE THERAPY SUPPLY CHAIN SOFTWARE MARKET: RESEARCH COVERAGE Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the cell and gene therapy supply chain software market, focusing on key market segments, including process component, type of software, mode of deployment, scale of operation and key geographical regions. Market Landscape: A comprehensive evaluation of cell and gene therapy supply chain software solutions, considering various parameters, such as type of software, key features, application area, mode of deployment, scale of operation, regulatory guidelines followed and type of end-user. Additionally, it includes a detailed list of developers providing cell and gene therapy supply chain software solutions, along with analysis based on various parameters, such as year of establishment, company size (in terms of employee count), location of headquarters (North America, Europe, Asia-Pacific, and rest of the world) and most active players based on the number of software solutions offered. Company Competitiveness Analysis: A comprehensive competitive analysis of cell and gene therapy supply chain software solution providers, examining factors, such as developer strength and product portfolio strength. Company Profiles: In-depth profiles of key cell and gene therapy supply chain software solution providers, focusing on company overviews, software solutions portfolio, financial information, recent developments and an informed future outlook. Funding and Investment Analysis: A detailed evaluation of the investments made in this domain, encompassing seed funding, venture capital, debt financing, grants / awards, capital raised from IPOs and subsequent offerings. Partnerships and Collaborations: An analysis of partnerships established in this sector, since 2019, covering acquisitions, platform utilization agreements, service alliances, platform integration agreements, product development agreements, service agreements and other agreements. Platform Utilization Agreements in Supply Chain Software Solutions Market: An in-depth analysis of the platform utilization agreements inked in this domain since 2019, providing information on the different types of software utilized by end-users in the cell and gene therapy supply chain. Stakeholder Need Analysis: A qualitative evaluation of the current and future needs of various stakeholders in the cell and gene therapy supply chain, including patients, healthcare providers, collection centers, manufacturers, logistics service providers and regulators. This section provides a summary of the distinct needs of these stakeholders and presents our opinion (drawn from historical and current trends) on the impact of these needs on the supply chain and how the industry is preparing to cater to these needs. Market Impact Analysis: The report analyzes various factors such as drivers, restraints, opportunities, and challenges affecting the market growth. Sample Players in the Cell and Gene Therapy Supply Chain Software Market, Profiled in the Report Include: Azenta Life Sciences Biocair BioLife Solutions CareDx Cryoport Lonza NMDP BioTherapies TraceLink TrakCel Veeva Systems Emerson LabVantage Solutions Marken MasterControl QuickSTAT Siemens Stafa Cellular Therapy Steiner STEMSOFT Software TECHNIDATA Thermo Fisher Scientific KEY QUESTIONS ANSWERED IN THIS REPORT How many companies are currently engaged in this market? Which are the leading companies in this market? What kind of partnership models are commonly adopted by industry stakeholders? What are the factors that are likely to influence the evolution of this market? What is the current and future market size? What is the CAGR of this market? How is the current and future market opportunity likely to be distributed across key market segments? REASONS TO BUY THIS REPORT The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants. Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies. The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects. ADDITIONAL BENEFITS Complimentary PPT Insights Packs Complimentary Excel Data Packs for all Analytical Modules in the Report 10% Free Content Customization Detailed Report Walkthrough Session with Research Team For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Cell and Gene Therapy Supply Chain CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
Yahoo
21 minutes ago
- Yahoo
Asimily Adds Enhanced IoT Password Management and Device Patching to Its Comprehensive Security Platform
SUNNYVALE, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Asimily, the only complete IoT, OT, and IoMT Risk Mitigation Platform, today announced the release of several new innovative features designed to help organizations across all industries efficiently secure and manage IoT devices while continuing down its path of cybersecurity innovation. These features are: IoT Password Management significantly simplifies the execution of password best practices across devices from multiple manufacturers. IoT Patching offers a 200% increase in supported manufacturers whose devices can now be automatically updated by Asimily. An intuitive new user interface designed for speed and efficiency, particularly for busy security and IT teams. 'Organizations with device fleets have always struggled to keep them updated. Unlike servers and operating systems, there is no streamlined process owned by the software manufacturer for IoT. This has always forced organizations to devote significant time and money to this essential line of defense,' said Shankar Somasundaram, CEO of Asimily. 'With our new IoT Management module and its Password Management and Patching capabilities, devices get automatically and fully updated faster with far less time and effort, helping prevent successful attacks from establishing a foothold within a company's networks.' IoT devices, such as printers, IP cameras, teleconference devices and network access points, are increasingly common targets for cyberattacks. Securing and managing IoT fleets requires the right software, processes, and skilled personnel to balance operational functionality and security. These features join the Asimily platform as crucial components, purpose-built to address the unique challenges associated with IoT Unauthorized Access with IoT Password Management Under the IoT Management module, Asimily has added IoT Password Management. This feature helps organizations enforce stronger credential policies and reduce the risk of unauthorized access to critical IoT infrastructure. It makes organizational adherence to best practices – strong passwords, no re-use – much easier while still allowing devices to operate with minimal interruption. Asimily's IoT Patching and IoT Password Management work together to prevent unauthorized access, allowing patching to be performed with a click, according to a schedule, or automatically. Increased Manufacturer Support for IoT Management Asimily has expanded its manufacturer support for IoT Management. This broader support ensures that even more devices can be automatically patched with Asimily, enabling better security for organizations. As businesses across industries continue to adopt new IoT devices, the expansion of this feature enables organizations to confidently lean into IoT while scaling security practices as their fleet grows. Since the initial launch of IoT Patching in March, 2025, the number of supported vendors has doubled, making thousands more customer devices easily updatable. Asimily is on track to increase the number of supported vendors by 400% within a year, dramatically expanding its direct-patching coverage. New User Interface Asimily recently refreshed its user interface to simplify adoption, organize crucial features around common workflows, reduce friction to accomplish critical risk mitigation tasks, and support a best-in-class user experience. Driven by extensive research and testing, the new interface reinforces Asimily's commitment to innovation and enables users to take decisive action across IoT, OT, and IoMT infrastructure. Ready to Strengthen Your IoT Security? See how Asimily's new capabilities make device management faster, safer, and easier than ever here. About Asimily Asimily has built an industry-leading risk management platform that secures IoT devices for organizations in healthcare, manufacturing, higher education, government, life sciences, retail, and finance. With the most extensive knowledge base of IoT and security protocols, Asimily inventories and classifies every device across organizations, both connected and standalone. Because risk assessment—and threats—are not a static target, Asimily monitors organizations' devices, detects anomalous behavior, and alerts operators to remediate any identified anomalies. With secure IoT devices and equipment, Asimily customers know their business-critical devices and data are safe. For more information on Asimily, visit Asimily ContactKyle Petersonkyle@ A photo accompanying this announcement is available at
Yahoo
21 minutes ago
- Yahoo
Rare Earth Magnets Market Report 2026-2036, with Detailed Analysis of 29 Leading Companies Across the Rare Earth Magnet Value Chain
In 2025, the rare earth magnet market faces unprecedented pressures due to geopolitical tensions, supply chain disruptions, and soaring demand from emerging technologies such as electric vehicles and robotics. China's export controls have particularly impacted industries like defense and Tesla's humanoid robots, causing significant ripple effects worldwide. The U.S.'s strategic interventions, including a $400 million investment in MP Materials and Apple's $500 million recycling partnership, highlight efforts to lessen dependency on Chinese exports. The demand for rare earth magnets, valued at $19 billion, continues to grow, underscoring the necessity for alternative technologies and robust domestic supply chains. The report examines the entire supply chain, from mining to recycling, and profiles key industry players. Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "Global Rare Earth Magnets Market 2026-2036" report has been added to offering. The rare earth magnet market stands at a critical juncture in 2025, shaped by unprecedented geopolitical tensions, supply chain disruptions, and explosive demand growth from emerging technologies. The industry's strategic importance has become paramount as governments and corporations recognize these materials as essential infrastructure for the global energy transition and technological advancement. The most significant recent development has been China's implementation of export controls on rare earth magnets beginning in April 2025, which triggered immediate supply chain disruptions across multiple industries. China's rare earth magnet exports to the United States experienced dramatic volatility, with shipments initially halted before surging 660% in June 2025 following trade negotiations. This rebound, while substantial, still leaves overall 2025 exports trailing previous year levels, demonstrating the fragility of current supply arrangements. The export restrictions particularly impacted critical applications including defense systems, electric vehicles, and emerging technologies like Tesla's Optimus humanoid robots. Ford halted production at its Chicago plant due to magnet shortages, while companies across industries depleted stockpiles while scrambling for alternative sources. Despite a temporary trade framework announced in June 2025, implementation remains problematic with companies facing ongoing uncertainty about future supply availability. The crisis has accelerated fundamental restructuring of global rare earth magnet supply chains. The U.S. Department of Defense's $400 million investment in MP Materials represents the largest government intervention in the sector, aimed at creating domestic magnet production capabilities. MP Materials has strategically halted all rare earth exports to China as of April 2025, redirecting focus toward domestic processing and magnet manufacturing at its Mountain Pass facility. Apple's $500 million partnership with MP Materials for recycling facility development exemplifies industry efforts to build resilient domestic supply chains. These initiatives reflect growing recognition that supply chain diversification requires comprehensive investment across the entire value chain, from mining through final magnet production. However, analysts warn that developing complete alternatives to Chinese capabilities will require years rather than months, given the complex separation and processing technologies involved. Market fundamentals remain exceptionally strong despite supply disruptions. Global rare earth magnet demand approaches 385,000 tonnes annually in 2025, valued at approximately $19 billion, with compound annual growth of 7.8% driven primarily by automotive electrification and renewable energy deployment. Emerging applications promise even more dramatic growth. Robotics, currently a small demand category, is forecast to become the single largest driver of neodymium-iron-boron (NdFeB) magnet consumption by 2040, driven by professional service robots in manufacturing, hospitality, and transportation. The humanoid robotics sector alone could require massive magnet quantities as production scales toward potential deployment of billions of units. Rising costs and supply uncertainty are driving intensive research into alternative magnet technologies. Cerium-based formulations are gaining attention as substitutes for dysprosium-enhanced magnets, with cerium offering advantages as a light rare earth element avoiding current export restrictions. Companies like Volkswagen's Scout Motors are exploring magnet-free motor designs, while automakers broadly investigate reduced-magnet architectures. However, these alternatives often involve performance trade-offs that limit applicability in high-performance applications. The concept of "demand destruction" through technological substitution represents a long-term market risk, but near-term demand growth from electrification continues to outpace substitution efforts. The rare earth magnet market's evolution represents a fundamental shift from commodity trading toward strategic resource management, with profound implications for global technology deployment, national security, and the pace of energy transition. Success in navigating these challenges will determine which nations and companies maintain technological leadership in the emerging clean energy economy. The Global Rare Earth Magnets Market 2026-2036 report provides the most comprehensive analysis of the rapidly evolving rare earth permanent magnet industry, delivering critical insights into market dynamics, supply chain vulnerabilities, technological innovations, and strategic opportunities across key application sectors. This authoritative 270-page plus report combines deep technical expertise with extensive market research to deliver actionable intelligence for stakeholders navigating the complex rare earth magnet ecosystem. As global demand for high-performance magnetic materials accelerates driven by electrification megatrends, renewable energy deployment, and emerging technologies including humanoid robotics, the rare earth magnet market faces unprecedented supply chain challenges and strategic realignment. With China's dominant position in production and processing creating geopolitical risks, alternative supply chain development has become a critical priority for governments and corporations worldwide. This report examines the complete rare earth magnet value chain from mining and separation through metallization, manufacturing, and recycling, providing detailed analysis of production capacity forecasts, demand projections by application segment, technological innovation pathways, and strategic recommendations for market participants. The analysis covers neodymium-iron-boron (NdFeB) and samarium-cobalt (SmCo) permanent magnet technologies across automotive, wind energy, consumer electronics, data centers, robotics, medical imaging, aerospace, marine, and industrial automation applications. Report contents include: Critical materials classification and rare earth magnet technology fundamentals Global market sizing, demand projections, and geographic distribution analysis Supply chain architecture assessment and strategic implications Regulatory environment evolution and policy framework impact Supply Chain and Value Chain Analysis Complete value chain structure from mining through magnet manufacturing Geographic production stage distribution and regional cluster development Market entry barriers, implementation challenges, and competitive dynamics 2025 export restriction impact assessment on dysprosium, terbium, and NdFeB alloys Rare Earth Mining and Production Global mining landscape with detailed regional development analysis North American, Australian, European, South American, and African project pipelines Hard rock versus ionic clay deposit comparison and processing technologies Mining economics, financial modelling, and resource discovery lifecycle analysis Processing and Separation Technologies Comprehensive processing technology comparison including hydrometallurgical and bioleaching methods Solvent extraction, chromatography, and multi-line separation system analysis Global processing capacity forecasts and geographic distribution projections Technology innovation roadmap and development priorities Magnet Manufacturing and Technology Metallization process fundamentals and global capacity control analysis NdFeB and SmCo magnet technology comparison and performance characteristics Sintered and bonded magnet manufacturing processes and innovation developments Grade classification, performance specifications, and cost structure analysis Application Market Analysis Electric vehicle and e-mobility market demand forecasts with motor technology assessment Wind energy sector analysis including turbine technology and magnet requirements Consumer electronics, data centers, and hard disk drive market dynamics Robotics and humanoid robot technology platform analysis Medical imaging, aerospace, marine, and industrial automation applications Recycling Technologies and Circular Economy Short-loop and long-loop recycling technology comparison and performance analysis Feedstock sources, pre-processing challenges, and automation integration Market barriers assessment and industry outlook through 2036 Value chain evolution and circular supply chain development Market Forecasts and Strategic Analysis Production capacity forecasts by geographic region (2026-2036) Demand projections by application segments and materials Supply-demand balance analysis and shortage risk assessment Revenue forecasts, investment opportunities, and risk assessment framework Technology innovation roadmap and competitive dynamics evolution Company Profiles and Competitive Intelligence Detailed analysis of 29 leading companies across the rare earth magnet value chain Strategic positioning, technology focus, and market development initiatives Investment activities, partnership strategies, and capacity expansion plans The report provides comprehensive profiles of 29 leading companies across the rare earth magnet value chain including: Arafura Resources Limited Australian Strategic Materials Ltd (ASM) Carester (Caremag) Cyclic Materials Energy Fuels Inc. Hastings Technology Metals Limited HyProMag Ionic Rare Earths Ionic Technologies JL Mag Lynas Rare Earths Limited MagREEsource Materials Nexus Metalysis MP Materials Corporation Neo Performance Materials Niron Magnetics and more. These profiles examine strategic positioning, technology capabilities, production capacity, market focus, and development initiatives across mining, processing, manufacturing, and recycling operations. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Connectez-vous pour accéder à votre portefeuille
